CPT 0045U Pathology/Laboratory
mRNA gene analysis of 12 genes in breast ductal carcinoma in situ tumor tissue Cost
Body System: General
Medicare Facility Rate
$3,873
CMS PFS CY2026
Medicare Non-Facility Rate
$3,873
Office/clinic setting
Frequently Asked Questions
How much does mRNA gene analysis of 12 genes in breast ductal carcinoma in situ tumor tissue cost?
The Medicare facility rate is $3,873. Commercial insurance typically pays 150-250% of Medicare rates (varies).
How much does mRNA gene analysis of 12 genes in breast ductal carcinoma in situ tumor tissue cost without insurance?
Without insurance, you may pay the hospital's chargemaster rate, which is often 300-500% of Medicare. Ask about cash-pay discounts — many facilities offer 20-40% off for self-pay patients. The Medicare baseline for this procedure is $3,873.